Faculty Information - TOKI Daisuke

（Last updated : 2026-05-14 16:16:07）

TOKI Daisuke
Department School of Medicine(Tokyo Women's Medical University Adachi Medical Center), School of Medicine

Position

■ Published papers

1.	Original article	Efficacy and safety of nivolumab plus cabozantinib in octogenarian patients with advanced renal cell carcinoma. 2025/10
2.	Original article	A case of complete remission of bilateral upper tract carcinoma in situ following retrograde bacillus calmette–guérin (BCG) instillation via open- ended ureteral catheters after failure using Double- J stents. 2025/09/17
3.	Case report	Whole exome sequencing identified mutations of forkhead box I 1 (FOXI1), keratin 6 C (KRT6C) and gap junction protein delta 2 (GJD2) in a low-grade oncocytic tumor of the kidney: a case report. 2025/02
4.	Original article	Effects of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. 2023/10
5.	Original article	Albumin-to-alkaline phosphatase ratio as a novel prognostic marker of nivolumab monotherapy for previously treated metastatic renal cell carcinoma. 2021/09
6.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation. 2021/06
7.	Original article	Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7-years of follow-up after renal transplantation. 2020/12
8.	Case report	Multiple myeloma with testicular involvement: A case report. 2019/09
9.	Original article	Assessment of 4 cases of kidney transplantation from hepatitis C virus antibody-positive and RNA-negative donors to antibody-negative recipients. 2016/09
10.	Original article	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. 2016/07
11.	Original article	Post-transplant lymphoproliferative disorder in kidney transplant recipients: A single-center experience in Japan. 2016/04
12.	Original article	ABO-Incompatible living kidney transplants: Evolution of outcomes and immunosuppressive management. 2016/03
13.	Original article	Effects of low-dose rituximab therapy in patients with primary cytomegalovirus infection. 2015/12
14.	Case report	A Case of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation Associated With Variant Conversion in the Columbia Classification 2015/07
15.	Original article	Retroperitoneoscopic donor nephrectomy with multiple renal arteries does not affect graft survival and ureteral complications. 2014/12
16.	Original article	The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation. 2014/09
17.	Original article	Clinical and pathological analyses of transplant glomerulopathy cases. 2014/06
18.	Original article	The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience 2011/11
19.	Original article	Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy 2011/02
20.	Original article	Mild rhabdomyolysis after renal transplantation 2011
21.	Original article	Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys 2010/08
22.	Original article	New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. 2010
23.	Original article	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation:Long-term impact and risk factors 2009
24.	Original article	Blood group O recipients associated with early graft deterioration in Living ABO-incompatible kidney transplantation 2009
25.	Original article	Continent Orthotopic Ileal Neobladder After Kidney Transplantation in a Patient With Urothelial Cell Carcinoma Associated With Chinese Herb Nephropathy 2008/06
Display 5 items
Display all(25)

■ Academic conference presentation

1.	Therapeutic efficacy of Cabozantinib or Axitinib rechallenge for advanced renal cell carcinoma. （Poster notice，General） 2024/04/27
2.	The retrospective study of upfront cytoreductive nephrectomy for metastatic renal cell carcinoma. （Poster notice，General） 2024/04/25
3.	Effect of remote ischemic preconditioning on renal protection in patients undergoing robot-assisted laparoscopic partial nephrectomy. （Poster notice） 2023/04/21
4.	Safety and efficacy of nivolumab for patients with chronic kidney disease. （Speech，General） 2020/12/23
5.	Therapeutic benefit of lymphadenectomy during radical nephroureterectomy for elderly patients with upper tract urothelial carcinoma. （Speech，General） 2020/12/23
6.	Reduced risk of new occurrence or progression of sarcopenia by robot-assisted radical cystectomy compared to the open procedure. （Speech，General） 2020/12/22
7.	Clinical relevance of immunoglobulin M deposition in peritubular capillaries in ABO-incompatible kidney transplantation. （Poster notice，General） 2020/05/30
8.	The relationship between metformin and post-operative recurrence of renal cell carcinoma （Poster notice，General） 2019/10/24
9.	Immunoglobulin deposition in peritubular capillaries in ABO-incompatible kidney Transplantation （Speech，General） 2019/10/02
10.	Correlation between the HLA antibody screening test and the specificity identification test. （Poster notice，General） 2019/09/15
11.	Evaluation of Urine BK Virus-PCR Measurement as a Screening Tool for Kidney Transplant Recipients （Speech，General） 2018/11/24
12.	The Evaluation of Urine BK Virus PCR Measurement for Kidney Transplantation Recipients （Speech，General） 2018/10/05
13.	Predictive factors for immediate progression after nivolumab therapy for metastatic renal cell carcinoma. （Speech，General） 2018/04/20
14.	Once-daily versus twice-daily tacrolimus in living kidney transplantation: A Multicenter, parallel group, open-label, 5-year, randomized non-inferiority trial. （Poster notice，General） 2017/05/02
15.	A case discussion from Japan. （Speech，General） 2017/03/25
16.	Glomerular capillary C4d staining without evidence of rejection is associated with worse graft function in ABO-incompatible Kidney Transplantation. （Poster notice，General） 2016/06/13
17.	An Investigation of 13 Cases of Membranous Nephropathy of the Donor Origin Accidentally Detected by 0-h Renal Biopsy During Kidney Transplantation （Poster notice，General） 2015/11/07
18.	Incidence of hepatitis B virus reactivation in kidney transplant patients who received rituximab administration. （Poster notice，General） 2015/05/05
19.	Interstitial fibrosis is the critical determinant of impaired renal function in transplant glomerulopathy. （Poster notice，General） 2015/05/03
20.	Outcome of kidney transplantation from obese living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
21.	Outcome of kidney transplantation from older living donors: Histological evaluation using zero-time biopsy specimens. （Poster notice，General） 2015/05/03
22.	Outcome of kidney transplantation using right versus three left renal arteries after retroperitoneoscopic donor nephrectomy:A single-center experience of 764 cases. （Poster notice，General） 2015/05/03
23.	Excellent outcomes of prophylactic rituximab administration with plasmapheresis in kidney transplant recipients with focal segmental glomerulosclerosis. （Poster notice，General） 2015/05/02
24.	Intimal arteritis associated with subsequent graft dysfunction in ABO-incompatible kidney transplantation. （Poster notice，General） 2015/05/02
25.	Efficacy of rituximab, an anti-CD20 antibody for preventing hemolysis due to passenger leucocyte syndrome (PLS). （Poster notice，General） 2014/07/30
26.	Analysis of predictive and preventive factors for de novo DSA in Non-HLA sensitized kidney transplant recipients. （Poster notice，General） 2014/07/29
27.	Long-term (more than 20 years) outcome of ABO-incompatible living donor kidney transplantation: A single center experience. （Speech，General） 2014/07/29
28.	Outcomes of pure retroperitoneoscopic live donor nephrectomy (RPLDN): single center experience of 764 cases. （Poster notice，General） 2014/07/29
29.	Outcomes of retroperitoneoscopic live donor nephrectomy in patients with renal artery aneurysm. （Poster notice，General） 2014/07/29
30.	Retroperitoneoscopic procurement of kidneys with multiple renal arteries does not affect graft survival and ureteral complications. （Poster notice，General） 2014/07/29
31.	The correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression including rituximab. （Speech，General） 2014/07/29
32.	Lower incidence rate of BK virus nephropathy, as detected by PCR screening, associated with lower doses of Tac/MMF at Tokyo Women's Medical University. （Poster notice，General） 2014/07/28
33.	Changes in ABO-blood type antibody titers after single-dose rituximab administration. （Poster notice，General） 2014/07/27
34.	Long-term outcomes of living donor kidney transplantation in flow cytometry crossmatch-positive patients: A single-center experience. （Poster notice，General） 2014/07/27
35.	Preliminary outcome of desensitization with super high dose IVIG, plasmapheresis, and rituximab for crossmatch-positive (highly sensitized) kidney transplant recipients. （Poster notice，General） 2014/07/27
36.	Comparative Study of Adverse Events and Lymphocyte Recovery in Living Kidney Transplantation Patients Treated with/without Rituximab, a B Cell-Depleting Treatment （Poster notice，General） 2013/05/21
37.	Incidence of Malignancy after Kidney Transplantation in the New Era of Immunosuppression （Poster notice，General） 2013/05/21
38.	Involvement of Alternative Activated Macrophages in Renal Allograft Fibrosis （Speech，General） 2012/06/05
39.	Trangent Induction of Lymphopenia Breakdown Peripheral Tolerance Against Allogenic Cardiac Graft Established by Co-Stimulation Blockade （Speech，General） 2011/05/03
40.	Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors （Speech，General） 2010/05
41.	Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation （Speech，General） 2010/05
42.	Outcome of kidney transplantation from living older donors: histologiucal evaluation using zero-time biopsy （Speech，General） 2010/05
Display 5 items
Display all(42)

■ Education

2005/04～2009/03

〔Doctoral course〕〔Doctorial Course〕, Graduate School, Division of Medical Sciences, Tokyo Women's Medical University, Completed